Medications

FDA approves first targeted therapy for HER2-low breast cancer

The U.S. Food and Drug Administration has approved Enhertu (am-trastuzumab-deruxtecan-nxki), an intravenous infusion treatment for patients with unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-low ...

Neuroscience

Seizures may increase dementia risk for young stroke survivors

Young stroke patients who have a seizure following their diagnosis are two and a half times more likely to develop dementia than patients who don't experience seizures, according to a new study by Penn State College of Medicine ...

page 1 from 35